Sadhak Sengupta

Sadhak Sengupta

Company: Triumvira Immunologics

Job title: Associate Director, Immunology


Creating Effective and Safe TAC T Cell Therapies by Targeting Compartmentalized Surface Antigens in Solid Tumors 10:00 am

• The TAC receptor co-opts the endogenous TCR for efficacious and safe T cell anti-tumor responses without MHC restriction • Compartmentalized surface antigens add to the repertoire of novel tumor-selective targets • Development status of TAC T cell products in the treatment of solid tumorsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.